A low-dose, bolus dexmedetomidine technique did not prolong the time to home discharge when administered for sedation during vitreoretinal surgery. Managerial concerns about such use prolonging discharge times following vitreoretinal surgery are unwarranted.
Epstein et al. (Tue,) studied this question.